[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"functional-limitation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:functional-limitation":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,51],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100637528","phase-i-randomized-controlled-trial-of-functional-resistance-training-in-older-cancer-survivors-the-aces-trial-100637528",false,"NCT07606313","Phase I Randomized Controlled Trial of Functional Resistance Training in Older Cancer Survivors: The ACES Trial","ACES: Advancing Capacity to Integrate Exercise Into the Care of Older Cancer Survivors","ACES","Inclusion Criteria:\n\n* Age 65 years of age or older\n* Diagnosed with stage I-IV cancer =\\\u003C 5 years ago\n* Completed surgery, chemotherapy, or radiation therapy \\> 3 months ago (concurrent maintenance therapy, such as hormone therapy for breast or prostate cancer, is permissible)\n* Self-report at least one limitation in Activities of Daily Living (ADLs) OR at clinical risk of developing ADL impairment as evidenced by a 3-meter timed-up-and-go time \\> 13.5 seconds or 5-time chair stand time \\> 12 seconds\n* Able to ambulate independently; reliance on assistive devices other than a wheelchair is allowed\n* Currently underactive (an average of \\\u003C 30 minutes of moderate-vigorous intensity exercise 3 days\u002Fweek over the past four weeks)\n* Willing to be randomized into any of the three study arms and attend 80% or more of planned exercise sessions\n* Home internet sufficient for videoconferencing\n\nExclusion Criteria:\n\n* Contraindication to moderate intensity exercise\n* Health or medical condition that affects movement or neurological disorder, or medication that contraindicates participation in live remote resistance exercise\n* Cognitive impairment consistent with moderate dementia (confirmed by a Montreal Cognitive Assessment (MoCA) score \\\u003C 14). Cognitive impairment consistent with early-stage dementia (a MoCA score of \\\u003C20) unless a research partner (e.g., family member, caregiver, close friend) can also be consented and can assist in answering the survey questions, participating in the performance tests, or giving informed consent.\n* Not fluent in English and therefore incapable of answering survey questions, following directions during exercise or performance testing, and providing informed consent in English","ALL","65 Years",{"count":20,"type":21},150,"ESTIMATED","INTERVENTIONAL",[24],"NA","The study will assess the feasibility and preliminary efficacy of live, online supervised group functional resistance training in older cancer survivors who may have difficulty with independent functioning. The study design is a three-arm parallel group randomized controlled trial (immediate resistance training, delayed resistance training, stretching placebo) in 150 older cancer survivors. The resistance training program will be compared to two different types of common control groups: a stretching placebo group and a delayed intervention group. By using two control conditions, this study can also inform the design of future randomized trials on the selection of an appropriate control group.",[27,28,29,30],"Hematopoietic and Lymphatic System Neoplasm","Malignant Solid Neoplasm","Cancer","Functional Limitation",[29,32,33,34,35,36,37],"Exercise","Cancer survivor","Functional limitation","Clinical trial","Older adult","Feasibility","NOT_YET_RECRUITING","2026-05-21",{"date":41,"type":42},"2026-05-26","ACTUAL",{"date":44,"type":21},"2026-05-18",{"date":46,"type":21},"2028-08-31",{"name":48,"class":49},"OHSU Knight Cancer Institute","OTHER",1,{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":60,"targetDuration":4,"studyType":62,"phases":4,"briefSummary":63,"conditions":64,"keywords":69,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":50},"100617090","impact-evaluation-of-breizh-fabribus-intervention-for-personalized-assistive-technology-creation-or-adaptation-100617090","NCT07314099","Impact Evaluation of Breizh Fabribus Intervention for Personalized Assistive Technology Creation or Adaptation","Évaluation d'Impact de l'Intervention du Breizh Fabribus Pour la création ou l'Adaptation d'Aide Technique personnalisée (BFB-IMPACT)","BFB-IMPACT","Inclusion Criteria:\n\n* Any person who has received assistance from BFB for the creation or adaptation of assistive technology\n\nExclusion Criteria:\n\n* objection to the use of their data\n* Sollicitation but no delivery of technical assistance by BFB",true,{"count":61,"type":21},70,"OBSERVATIONAL","In France, more than 14 million individuals report severe functional limitations, and nearly 5 million struggle with essential daily activities. Traditional barriers to assistive technology-high costs, lengthy funding delays, lack of information, and poorly fitting off-the-shelf solutions-frequently lead to underuse, dissatisfaction, and environmental waste The BFB-IMPACT study evaluates the real-world effectiveness of Breizh Fabribus, a mobile workshop equipped with 3D printing and laser-cutting that produces and customizes assistive devices on site for people with disabilities in Finistère, France region. This retrospective, single-center investigation includes all service recipients from January 2024 to December 2025 and measures changes in users' ability to perform targeted activities at three months post-intervention. Secondary outcomes include user satisfaction and device utilization. Data collection occurs from October 2025 to May 2026, with analysis anticipated in June 2026 and results published in the second half of 2026.",[65,30,66,67,68],"Amputation","Autonomy of Older People","Handicaps Physical","Autonomy",[70,71,72,73,74,75,76],"mobile workshop","3D printing","laser cutting","personalized devices","user satisfaction","functionnal autonomy","disability","RECRUITING","2025-12-17",{"date":80,"type":42},"2026-01-02",{"date":82,"type":21},"2025-12",{"date":84,"type":21},"2026-11",{"name":86,"class":49},"Fondation Ildys"]